Nashville Neuroscience Group /ID# 231642 — Nashville, Tennessee

Nashville Neuroscience Group /ID# 231642 is a clinical research site located in Nashville, Tennessee, United States 37203.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

Nashville Neuroscience Group /ID# 231642 has participated in 1 clinical trials.

Therapeutic areas: Episodic Migraine.

Sponsors: AbbVie.

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Nashville Neuroscience Group /ID# 231642?

Nashville Neuroscience Group /ID# 231642 has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Nashville Neuroscience Group /ID# 231642 conducted?

Nashville Neuroscience Group /ID# 231642 has 1 clinical trials on record. Their work covers Episodic Migraine.

Is Nashville Neuroscience Group /ID# 231642 accredited by Crixeo Health?

Nashville Neuroscience Group /ID# 231642 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Nashville Neuroscience Group /ID# 231642?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.